Naltrexone Poa Pharma (Naltrexone Hydrochloride)

Naltrexone, the active ingredient in Naltrexone Poa Pharma, is an opioid antagonist presented as an oral formulation for oral use. It treats alcohol dependence and opioid dependence in adult patients, helping to reduce cravings and block the reinforcing effects of these substances.

GNH USA supplies Naltrexone Poa Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naltrexone is used in the management of disorders related to alcohol and opioid use, acting on the central nervous system to diminish reinforcing effects.

- Alcohol dependence: reduces cravings and the risk of relapse in adults. - Opioid dependence: blocks opioid receptors to support abstinence and prevent relapse.

Naltrexone may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Headache: occasional tension‑type headache. - Dizziness: transient light‑headedness. - Fatigue: feeling of reduced energy.

Serious or Rare Side Effects: - Hepatotoxicity: elevated liver enzymes or liver injury. - Severe depression or suicidal thoughts: mood changes requiring immediate attention. - Allergic reactions: rash, pruritus, or anaphylaxis.

Before initiating therapy, clinicians should evaluate patient history and monitor for specific risks.

- Liver function assessment: check baseline enzymes and monitor periodically. - Depression monitoring: watch for mood changes, especially in patients with prior psychiatric illness. - Opioid use avoidance: do not co‑administer with opioid analgesics to prevent precipitated withdrawal. - Renal impairment caution: adjust monitoring in patients with reduced kidney function. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Naltrexone can interact with several medication classes, requiring careful management.

Major Interactions (Avoid): - Opioid agonists (e.g., morphine, oxycodone): may precipitate acute withdrawal. - Alcohol: concurrent use can increase hepatotoxic risk. - Disulfiram: combined hepatotoxic potential.

Moderate Interactions (Monitor Closely): - Antidepressants (e.g., SSRIs): monitor for additive central nervous system effects. - Antihypertensives: observe for possible blood pressure changes.